Derma Sciences, Inc. Common Stock (DE)
DSCI
DSCI was delisted on the 23rd of February, 2017.
52 hedge funds and large institutions have $87.2M invested in Derma Sciences, Inc. Common Stock (DE) in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 15 increasing their positions, 18 reducing their positions, and 11 closing their positions.
12% more capital invested
Capital invested by funds: $78M → $87.2M (+$9.14M)
15% less funds holding
Funds holding: 61 → 52 (-9)
17% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 18
73% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
+$1.02M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$564K |
| 3 |
Goldman Sachs
New York
|
+$96.5K |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$75.9K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$56.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$458K |
| 2 |
D.E. Shaw & Co
New York
|
-$200K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$173K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$131K |
| 5 |
CMBA
C.M. Bidwell & Associates
Honolulu,
Hawaii
|
-$107K |
DSCI Hedge Fund Activity: Q4 2016 in Review
52 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Derma Sciences, Inc. Common Stock (DE) (DSCI) for Q4 2016, worth a combined $87.2M — up 12% from $78M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of DSCI and 3 opened new positions — a net loss of 8 holders — while 18 trimmed existing stakes and 15 added.
The largest buyer was Royce & Associates, adding an estimated $1.02M. The largest seller was Stonepine Capital Management, exiting entirely with an estimated $458K sold.
- 52 institutional investors held Derma Sciences, Inc. Common Stock (DE) (DSCI) as of Q4 2016, down from 61 in Q3 2016.
- Funds reported $87.2M of Derma Sciences, Inc. Common Stock (DE) stock for Q4 2016, up 12% quarter-over-quarter.
- 3 funds opened new Derma Sciences, Inc. Common Stock (DE) positions in Q4 2016 and 11 closed out, a net change of -8 holders.
- The largest Derma Sciences, Inc. Common Stock (DE) buyer in Q4 2016 was Royce & Associates, an estimated $1.02M added.
- The largest Derma Sciences, Inc. Common Stock (DE) seller in Q4 2016 was Stonepine Capital Management, an estimated $458K sold.
Based on aggregated 13F filings for Q4 2016.